Mitigation of Off-Target Adrenergic Binding and Effects on Cardiovascular Function in the Discovery of Novel Ribosomal S6 Kinase 2 Inhibitors

Author:

Fryer Ryan M.,Muthukumarana Akalushi,Chen Rong Rhonda,Smith James D.,Mazurek Suzanne Nodop,Harrington Kyle E.,Dinallo Roger M.,Burke Jennifer,DiCapua Frank M.,Guo Xin,Kirrane Thomas M.,Snow Roger J.,Zhang Yunlong,Soleymanzadeh Fariba,Madwed Jeffrey B.,Kashem Mohammed A.,Kugler Stanley Z.,O'Neill Margaret M.,Harrison Paul C.,Reinhart Glenn A.,Boyer Stephen J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference21 articles.

1. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs;Adams;J Am Vet Med Assoc,1984

2. Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach?

3. ETA Receptor Blockade With Atrasentan Prevents Hypertension With the Multitargeted Tyrosine Kinase Inhibitor ABT-869 in Telemetry-instrumented Rats

4. Boyer SJ Gao AD Guo X Kirrane TM Sarko CR Snow RJ Soleymanzadeh F Zhang Y (2011) Heterocyclic Compounds Containing an Indole Core. World Patent WO2011/071716A1. 16 Jun 2011.

5. Hydralazine and Isosorbide Dinitrate in Heart Failure

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3